Utah
|
87-0652870
|
|
(State
of Incorporation
or
Organization)
|
(IRS
Employer
Identification
No.)
|
3293
Harrison Boulevard, Suite 230, Ogden, Utah
|
84403
|
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
Large
accelerated filer
|
o
|
Accelerated
filer
|
o
|
||
Non-accelerated
filer
|
o
|
Smaller
reporting company
|
T
|
||
(Do
not check if a smaller reporting company)
|
Title
of Each Class of Securities to be Registered
|
Amount
to be Registered (1)
|
Proposed
Maximum Offering Price Per Share (2)
|
Proposed
Maximum Aggregate Offering Price (2)
|
Amount
of Registration Fee
|
Common
Stock, par value $0.001 per share
|
7,000,000
shares
|
$1.20
|
$8,400,000
|
$500.00
|
(1)
|
Pursuant
to Rule 416(a) under the Securities Act of 1933, as amended (the
“Securities Act”), this registration statement shall also cover any
additional shares of common stock that become issuable under the Bio-Path
Holdings, Inc. First Amended 2007 Stock Incentive Plan being registered
pursuant to this registration statement by reason of any stock dividend,
stock split, recapitalization or any other similar transaction effected
without the receipt of consideration which results in an increase in the
number of the registrant’s outstanding shares of common
stock.
|
|
(2)
|
Estimated
pursuant to paragraph (c) and (h) of Rule 457 under the
Securities Act solely for purposes of calculating the registration fee,
based upon the last reported sales price of the common stock as reported
on the OTCBB on December 16,
2008.
|
|
Item 1. Plan
Information.*
|
|
Item 2. Registrant Information and
Employee Plan Annual
Information.*
|
|
Item 3. Incorporation of Documents by
Reference.
|
·
|
Our
Annual Report on Form 10-KSB for the year ended June 30, 2007, filed
December 12, 2007 (in February 2008, we changed our fiscal year end to
December 31st);
|
·
|
Our
Quarterly Reports on Form 10-QSB for the following
periods:
|
Quarter
Ended
|
Filing
Date
|
|||
9/30/07
|
12/24/07
|
|||
12/31/07
|
2/12/08
|
|||
3/31/08
|
5/20/08
|
|||
6/30/08
|
8/14/08
|
|||
9/30/08
|
11/14/08
|
·
|
Our
Current Reports on Form 8-K:
|
Dated
|
Filing
Date
|
|||
2/14/08
|
2/19/08
|
|||
2/14/08
(form 8-K/A)
|
2/21/08
|
|||
2/21/08
|
3/07/08
|
|||
2/14/08
(form 8-K/A)
|
5/19/08
|
|||
6/24/08
|
6/24/08
|
|||
7/22/08
|
7/28/08
|
|||
9/22/08
|
10/16/08
|
·
|
Our
Form 8-A declared effective on September 10, 2008, registering our common
stock under Section 12(g) of the Securities Exchange Act of 1934, as
amended.
|
|
Item 4. Description of
Securities.
|
|
Item 5. Interests of Named Experts and
Counsel.
|
|
Item 6. Indemnification of Directors
and Officers.
|
|
Item 7. Exemption from Registration
Claimed.
|
|
Item 8. Exhibits.
|
Exhibit No.
|
Description
|
4.1
|
2007
Stock Incentive Plan *
|
5.1
|
Opinion
of Cohne Rappaport & Segal *
|
23.1
|
Consent
of Mantyla, McReynolds, LLC independent registered certified public
accountants for Registrant *
|
23.2
|
Consent
of Spector, Wong & Davidian, LLP, previous independent
registered certified public accountants for Registrant
*
|
23.3
|
Consent
of Cohne, Rappaport & Segal – contained in Exhibit
5.1
|
|
Item 9. Undertakings.
|
Bio-Path
Holding, Inc.
|
||
By
|
/s/
|
|
Peter
H. Nielsen
|
||
Chairman,
CEO, President, Principal Executive Officer, Principal Accounting Officer
and Principal Financial Officer
|
Signature
|
Title
|
Dated
|
|
||
Peter
H. Nielsen
|
Chairman,
CEO, President, Principal Executive Officer, Principal Accounting Officer
and Principal Financial Officer
|
December
9, 2008
|
Douglas
P. Morris
|
Vice
President of Corporate Development/Director
|
December
9, 2008
|
Dr.
Thomas Garrison
|
Director
|
December
9, 2008
|
Dr.
Gillian Ivers-Read
|
Director
|
December
9, 2008
|
Exhibit No.
|
Description
|
First
Amended 2007 Stock Incentive Plan *
|
|
Opinion
of Cohne Rappaport & Segal *
|
|
Consent
of Mantyla, McReynolds, LLC independent registered certified public
accountants for Registrant *
|
|
Consent
of Spector, Wong & Davidian, LLP, previous independent
registered certified public accountants for Registrant
*
|
|
23.3
|
Consent
of Cohne, Rappaport & Segal – contained in Exhibit
5.1
|